dimethylmethylene blue

07/01/2004 - "Evaluation of reliability for urine mucopolysaccharidosis screening by dimethylmethylene blue and Berry spot tests."
01/01/2001 - "The diagnosis of a mucopolysaccharidosis (MPS) can be achieved by non-enzymatic screening methods, including two-dimensional electrophoresis (2-D EP), and the dimethylmethylene blue (DMB) method. "
01/01/2001 - "Diagnostic screening for mucopolysaccharidoses by the dimethylmethylene blue method and two dimensional electrophoresis."
01/01/1993 - "Pitfalls of screening for mucopolysaccharidoses by the dimethylmethylene blue test."
04/01/1991 - "In contrast, the quantitative dimethylmethylene blue test (Clin Chem 1989;35:1472-7) detected an increased glycosaminoglycan content in all urine samples from mucopolysaccharidosis patients and gave no false-positive results. "

07/01/2003 - "Treatment of RBC with DMMB and red light resulted in enhanced potassium leakage and both short- and long-term haemolysis. "
11/01/2002 - "Quinacrine enhances vesicular stomatitis virus inactivation and diminishes hemolysis of dimethylmethylene blue-phototreated red cells."
11/01/2002 - "These results collectively suggest that despite its recognized affinity for viral nucleic acid, DMMB also binds to RBC membranes and that the bound dye is, in part, responsible for photoinduced hemolysis."
09/01/2002 - "Limited photoinactivation kinetics, use of low-volume 30 percent Hct RBCs, and hemolysis have restricted the practicality of the use of dimethylmethylene blue (DMMB) and light for RBC decontamination. "
11/01/2002 - "The addition of 500 pM quinacrine to oxygenated RBC before treatment with 3.6 microM dimethylmethylene blue (DMMB) and 219 mJ/cm2 red light resulted in an increased extracellular concentration of the sensitizer, increased extracelluar viral inactivation kinetics, and decreased hemolysis during 1-6 degrees C storage without alteration of quinacrine absorption properties. "

09/01/2001 - "DMMB photoinactivated human immunodeficiency virus by > 3.69 log10 under conditions that inactivated 3.33 log10 of vesicular stomatitis virus (VSV). "
11/01/2002 - "Quinacrine enhances vesicular stomatitis virus inactivation and diminishes hemolysis of dimethylmethylene blue-phototreated red cells."
01/01/2000 - "Photoinactivation of vesicular stomatitis virus (VSV) in stroma-free hemoglobin (SFH) was carried out using methylene blue (MB) or 1,9-dimethylmethylene blue (DMMB). "

01/01/2019 - "Despite describing some p53-related responses in cells challenged by photosensitization, our results also provide novel information on the consequences of DMMB phototoxicity."
01/01/2019 - "By challenging cells having different p53 protein levels, we investigated whether p53 modulates DMMB/light-induced phototoxicity and cell cycle dynamics. "
11/01/2019 - "1,9-Dimethyl-Methylene Blue Zinc Chloride Double Salt - DMMB is a potent phenothiazine derivative that presents high photodynamic action due to its high lipophilicity as well as a greater quantum yield of Singlet oxygen and phototoxicity when compared to other Photosensitizers. "

01/01/2019 - "DMMB photosensitization seems to induce mostly autophagy-associated cell death and S-phase cell cycle arrest with replication stress. "
01/01/2019 - "Despite describing some p53-related responses in cells challenged by photosensitization, our results also provide novel information on the consequences of DMMB phototoxicity."
11/20/2020 - "Photosensitization of cells previously incubated with nanomolar concentrations of 1,9-dimethyl methylene blue (DMMB), severely and specifically damages mitochondria and lysosomes, leading to a lipofuscin-related senescent phenotype. "